WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
Author: Business Wire
Stanton Optical Opens New Store in Boise Area
BOISE, Idaho–(BUSINESS WIRE)–Stanton Optical, a leading full-service optical retailer offering accessible and affordable eye care and eyewear, opened its newest location in Boise on Monday, December 14. Located at 1405 N. Milwaukee Street, the new st…
Global Glass Lens Market | $3.6 Billion Growth During 2020-2024 | Technavio
LONDON–(BUSINESS WIRE)– #GlobalGlassLensMarket–The Glass Lens Market will grow by $ 3.59 bn during 2020-2024
Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases
LONDON–(BUSINESS WIRE)– #GeneTherapy–Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases.
Kubota Vision Provides Update on Kubota Glasses – Wearable Device for Myopia Control
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company achieved a milestone b…
IVERIC bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that Glenn P. Sblendorio, CEO and President, will present at the 39th Annual J.P. Morgan Healthcare Conference on Jan. 14, 2021.
Horizon Therapeutics plc Announces Short-Term TEPEZZA® (teprotumumab-trbw) Supply Disruption Due to Government-Mandated (Operation Warp Speed) COVID-19 Vaccine Production
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced that it expects a short-term disruption in TEPEZZA (teprotumumab-trbw) supply as a result of recent government-mandated COVID-19 vaccine production orders related to Operation W…
Global Retinal Vein Occlusion (RVO) Epidemiology Forecast to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Vein Occlusion (RVO) – Epidemiology Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Retinal Vein Occlusion (RVO) – Epidemiology Forecast-2030’ report delivers an in-depth understa…
Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopia
NEW YORK–(BUSINESS WIRE)– #Eyenovia–Eyenovia has enrolled its first patients in the Phase 3 VISION-1 Study of MicroLine for the improvement in near vision in patients with presbyopia.
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
World Macular Oedema Disease Insights and Market Forecasts Report 2020-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Macular Oedema – Disease Insights and Market Forecasts to 2026” report has been added to ResearchAndMarkets.com’s offering. “Macular oedema: Disease Insights and Market Forecasts to 2026” report delivers an in-depth unders…
EyeQue Honored with Two CES 2021 Innovations Awards
NEWARK, Calif.–(BUSINESS WIRE)– #CES2021–EyeQue earns its fourth and fifth CES Innovations Awards for the latest smartphone vision test – EyeQue VisionCheck 2, now available on Kickstarter.
My Eyelab and Stanton Optical Unveil New Line of Disney-Themed Frames for Children
PALM SPRINGS, Fla.–(BUSINESS WIRE)–My Eyelab and Stanton Optical, leading retail brands of Now Optics offering accessible and affordable eye care and eyewear, announced today the release of an exclusive line of frames for children in the Disney, Marv…
Alnylam Announces 2021 Product and Pipeline Goals and Provides Program Updates at R&D Day
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is kicking off a virtual R&D Day event today. During the two-day event, the Company plans to showcase its commercial and R&D…
Avellino Expands Its Board of Directors and Welcomes New Executive Management Members
MENLO PARK, Calif.–(BUSINESS WIRE)– #avagen–Avellino announces three new board members and two new executive management members to the continuously growing precision medicine company.
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
FDA Approves Genentech’s Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a shorter two-hour infusion time for Ocrevus® (ocrelizumab)…
Ashvattha Therapeutics Announces Collaboration With Stanford University for Preclinical Development of a Novel Neuroimaging Agent, OP-801
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics, a biotech company focused on developing novel hydroxyl dendrimer therapeutics (HDTs) to treat unmet medical needs in inflammatory, oncology and ocular diseases, today announced the initiati…
Global Diabetic Retinopathy Market Insights, Epidemiology, and Market Report 2017-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diabetic Retinopathy – Market Insights, Epidemiology, and Market Forecast-2030” drug pipelines have been added to ResearchAndMarkets.com’s offering. This ‘Diabetic Retinopathy (DR) – Market Insights, Epidemiology, and Mark…
Global Eyeglasses Market 2020-2024: Market Analysis, Drivers, Restraints, Opportunities, and Threats – Technavio
LONDON–(BUSINESS WIRE)– #Eyeglasses–The Global Eyeglasses Market will grow by $ 41.98 bn during 2020-2024